Eylea (aflibercept) 40 mg/mL Injection: Uses, Safety, Cost
Quick summary Eylea 40 mg/mL solution for injection contains aflibercept, an anti-VEGF medicine used for certain retinal diseases. It is given by a healthcare professional as an intravitreal injection into the eye. Medical disclaimer:...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary
Eylea 40 mg/mL solution for injection contains aflibercept, an anti-VEGF medicine used for certain retinal diseases. It is given by a healthcare professional as an intravitreal injection into the eye.
Medical disclaimer: This article is for general information only. It does not replace the official patient leaflet, product information, or advice from an ophthalmologist, pharmacist, or other qualified clinician.
What is Eylea 40 mg/mL solution for injection in a vial?
Eylea is a prescription eye medicine that contains aflibercept. It is described as an anti-VEGF agent, meaning it works by blocking vascular endothelial growth factor (VEGF).
It is used for retinal conditions linked to abnormal blood vessel growth or fluid leakage in the eye. The original content highlights use in wet age-related macular degeneration (AMD), diabetic macular oedema, and retinal vein occlusion.
The medicine is administered by a healthcare professional into the vitreous of the eye. Patients should always follow the treatment plan and monitoring schedule set by their eye specialist.
How does Eylea work?
Eylea works by binding to VEGF and placental growth factor (PlGF). This helps reduce the signals that can drive abnormal blood vessel formation and leakage in the retina.
By limiting these processes, the treatment may help stabilize the retina and support vision preservation in the conditions for which it is used.
What conditions is Eylea used for?
The original content identifies Eylea as a treatment option for:
- Wet age-related macular degeneration (AMD)
- Diabetic macular oedema
- Retinal vein occlusion
These are serious eye conditions that require specialist assessment and follow-up. The exact use depends on the diagnosis made by the treating clinician.
How effective is Eylea for wet AMD?
The source content states that Eylea has been extensively studied in wet AMD and showed results comparable to ranibizumab in maintaining vision. It also notes that many patients experienced visual improvement after treatment began.
It further states that in clinical studies, over 95% of patients maintained or improved their vision after one year of treatment. This figure is included here as reported in the original content.
Eylea is also described as having a flexible dosing schedule, with injection intervals adjusted to individual needs by the treating specialist.
What are the possible side effects?
The original content says Eylea is generally well tolerated, but some side effects can occur. It specifically mentions:
- Intraocular pressure fluctuations
- Ocular discomfort
- Conjunctival hemorrhage
- Risk of infection at the injection site
It also notes that people with a history of glaucoma may need careful monitoring because pressure changes in the eye can occur.
If you notice unusual symptoms after an eye injection, such as worsening pain, marked redness, or sudden changes in vision, seek urgent medical advice.
What should patients know about long-term monitoring?
The original content emphasizes regular follow-up appointments. This is important because eye specialists may monitor vision, eye pressure, and any signs of complications over time.
Long-term care is especially relevant for people receiving repeated injections, since treatment response and tolerability can vary from person to person.
How is Eylea delivered?
The source content says Eylea originally came in a vial format and later transitioned to a pre-filled syringe format from April 2020. The aim was to improve standardization, convenience, and safety during preparation and administration.
Because this is an injectable eye medicine, administration should be performed by a trained healthcare professional. Patients should not attempt to inject it themselves unless specifically instructed by their specialist and product instructions.
What does the original content say about cost?
The original content states that Eylea can be expensive and that the price may vary by location, provider, and insurance coverage. It also notes that some patients may have access to assistance programs or partial coverage through health plans.
Because pricing changes over time and by country, it is best to confirm the current cost with the dispensing pharmacy, clinic, insurer, or official product source.
What should you verify with a doctor or pharmacist?
If you are reading about Eylea for yourself or someone else, it is sensible to confirm the following with a clinician or pharmacist:
- The exact diagnosis being treated
- Whether the vial or pre-filled syringe format applies in your setting
- The planned injection schedule
- What side effects need urgent review
- How the medicine is covered or supplied locally
Checking the official leaflet and product information is the safest way to confirm the latest details.
Frequently asked questions
▸ What is aflibercept injection used for?
The original content says aflibercept injection is used for eye conditions linked to abnormal blood vessel growth or fluid leakage, including wet AMD, diabetic macular oedema, and retinal vein occlusion.
▸ How does Eylea help the retina?
It blocks VEGF and PlGF, which helps reduce abnormal vessel growth and leakage in the retina.
▸ What side effects were mentioned in the source content?
The source content mentions eye pressure changes, ocular discomfort, conjunctival hemorrhage, and infection risk at the injection site.
▸ Is Eylea given as a self-injection?
No. It is administered by a healthcare professional as an intravitreal injection into the eye.
▸ Why can the cost vary so much?
The original content says cost can vary by location, provider, and insurance coverage, and that assistance may be available in some cases.
Safety reminder: Eye injections require specialist administration and follow-up. If you have new pain, redness, discharge, or sudden vision changes after treatment, seek urgent medical attention.
Key takeaways
Eylea 40 mg/mL contains aflibercept and is used for certain retinal diseases, including wet AMD, diabetic macular oedema, and retinal vein occlusion. It works by blocking VEGF and PlGF, and it is given by a trained healthcare professional as an eye injection.
For the most accurate and current information, always check the official product leaflet and speak with the treating eye specialist.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
- FDA Prescribing Information for Eylea (aflibercept)
- European Medicines Agency: Eylea
- NHS: Aflibercept eye injections
- MedlinePlus: Eye injections and retinal conditions
To improve this article with specific references, add a custom field named _aio_sources in the post editor and write one source per line using: Source title|Source URL.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.